Page last updated: 2024-10-25

citalopram and Neuroblastoma

citalopram has been researched along with Neuroblastoma in 3 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
" We assessed and compared the cytotoxicity of 2 SSRI, citalopram and escitalopram, on neuroblastoma cell lines."7.85Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation. ( Aissouni, Y; Chalus, M; Coll, G; Delétage, N; Gobron, S; Sakka, L; Sylvain-Vidal, V, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Rodríguez-Lavado, J1
Gallardo-Garrido, C1
Mallea, M1
Bustos, V1
Osorio, R1
Hödar-Salazar, M1
Chung, H1
Araya-Maturana, R1
Lorca, M1
Pessoa-Mahana, CD1
Mella-Raipán, J1
Saitz, C1
Jaque, P1
Reyes-Parada, M1
Iturriaga-Vásquez, P1
Pessoa-Mahana, H1
Sakka, L1
Delétage, N1
Chalus, M1
Aissouni, Y1
Sylvain-Vidal, V1
Gobron, S1
Coll, G1
Cinquanta, M1
Ratovitski, T1
Crespi, D1
Gobbi, M1
Mennini, T1
Simantov, R1

Other Studies

3 other studies available for citalopram and Neuroblastoma

ArticleYear
Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.
    European journal of medicinal chemistry, 2020, Jul-15, Volume: 198

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antidepressive Agents; Cell

2020
Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation.
    Oncotarget, 2017, Jun-27, Volume: 8, Issue:26

    Topics: Citalopram; Gene Regulatory Networks; Humans; Neural Stem Cells; Neuroblastoma; Selective Serotonin

2017
Carrier-mediated serotonin release induced by d-fenfluramine: studies with human neuroblastoma cells transfected with a rat serotonin transporter.
    Neuropharmacology, 1997, Volume: 36, Issue:6

    Topics: Animals; Calcium; Carrier Proteins; Citalopram; Fenfluramine; Humans; In Vitro Techniques; Membrane

1997